Amphastar Pharmaceuticals (AMPH) Current Deferred Tax Assets (2013 - 2015)

Amphastar Pharmaceuticals' Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $19.2 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 19.14% year-over-year to $19.2 million; the TTM figure through Sep 2015 stood at $19.2 million (up 19.14% YoY), while the FY2014 annual figure was $19.5 million, up 21.35% from the prior year.
• Current Deferred Tax Assets was $19.2 million for Q3 2015 at Amphastar Pharmaceuticals, roughly flat from $19.2 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $19.7 million in Q1 2015 to a low of $16.1 million in Q4 2013.
• Historically, Current Deferred Tax Assets has averaged $18.0 million across 3 years, with a median of $19.2 million in 2015.
• The sharpest annual moves came in 2014 and 2015: Current Deferred Tax Assets advanced 21.35% in 2014, then advanced 19.14% in 2015.
• A 3-year view of Current Deferred Tax Assets shows it stood at $16.1 million in 2013, then advanced by 21.35% to $19.5 million in 2014, then dropped by 1.83% to $19.2 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $19.2 million (Q3 2015), $19.2 million (Q2 2015), and $19.7 million (Q1 2015), per Business Quant data.